Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Activity at human CCK2 up to 10 uM
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of (Thr,Nle)-CCK-9 -induced inositol phosphate production in COS-7 cells expressing human CCK2 receptor
Assay data:4 Active, 3 Activity ≤ 1 µM, 4 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Selectivity ratio of IC50 measured in guinea pig cortex to that of IC50 for guinea pig pancreas
Assay data:32 Tested
Concentration required to inhibit CCK-A receptor/ Concentration required to inhibit CCK-B receptor
Assay data:3 Tested
Relative efficacy (1-30 uM) after incubation with CCK-8 (1 uM) tested in vitro
Assay data:8 Tested
SummaryRelated BioAssays by Target
Evaluated in vitro for Cholecystokinin type B receptor affinity by measuring its ability to displace tritiated CCK-8S bound on guinea pig brain Cholecystokinin type B receptor
Assay data:15 Active, 1 Activity ≤ 1 nM, 15 Activity ≤ 1 µM, 15 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
The concentration required for half maximal inhibition of the binding to Cholecystokinin type B receptor (CCK-B) from guinea pig cortical membrane
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
In vitro binding for half maximal inhibition of [125I]- cholecystokinin type B receptor in guinea pig cortex
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on